Communicating Science in the New Millennium by unknown
NJEHS News
Communicating Science in the
New Millennium
A two-day conference in January, "NIH:
Communicating Science and Health in the
New Millennium," underscored NIH's
renewed emphasis on ensuring that informa-
tion from basic and applied biomedical
research is made immediately available to
citizens, health providers, health educators,
and decision-makers. The conference, host-
ed by NIH Director Harold Varmus,
brought together 300 members of the NIH
communications community, along with
outside researchers, journalists, and adminis-
trators. The conference was the first one
held in the Natcher Building, a new, state-
of-the-art meeting and conference facility on
the NIH campus.
In his opening remarks at the meeting,
Varmus charged attendees to help NIH
address three challenges in communicating
research: recognizing what needs to be said,
delivering the message, and identifying and
responding to the audience NIH must reach,
which includes a diverse public with varying
levels of literacy. Anne Thomas, director of
the NIH Office of Communications and
chair of the conference, presented a video
during the opening session that highlighted
NIH communications and featured scenes of
the press conference conducted by Varmus,
NIEHS Director Kenneth Olden, and
NIEHS scientists following announcement of
the discovery ofthe breast cancer susceptibili-
ty gene, as well as a segment on Martin
Rodbell, NIH Scientist Emeritus at NIEHS
and co-recipient of the 1994 Nobel Prize in
Medicine.
Kathleen Hall Jamieson, dean of the
Annenberg School of Communication at
University of Pennsylvania, delivered the
conference's keynote presentation. Jamieson
pointed out that NIH must leave behind the
old transmission model of
communications, where
messages are simply impart-




she said, providing new
structures ofaccess to infor-
mation and allowing a dia-
logue with the public rather
than a lecture platform
from which to speak to pas-
sive listeners. Jamieson
noted that the news media
relies upon drama and con-
flict to define news, and
these elements sometimes
upstage or distort informa-
, ~~~~~~~~E
E # . I Z o~~~~~~~~c
Getrd Elion
tion about health and science in the news.
She also noted that NIH trust and credibility
are invaluable, and that in partnerships with
private industry to deliver health messages,
NIH should take care to avoid the appear-
ance ofcompromise which may lead to a loss
ofpublic trust.
The conference featured a series ofpanel
discussions followed by work group sessions
on topics such as health communications,
news/mass media, and reaching audiences of
ethnic populations, youth, patient cohorts,
and low literacy groups. In the work group
sessions, NIEHS reported pioneering efforts
in outreach to ethnic, low-income, and
underserved rural and urban communities.
The NIEHS outreach program serves as a
model for other NIH efforts.
Samuel Silverstein, president of the
Federation ofApplied Science and Experi-
mental Biology, asserted that NIH grantees
have a responsibility to acknowledge the
source oftheir research funding and to explain
notjust the results oftheir experiments but the
implications oftheir findings to the diagnosis,
prevention, and cure ofdisease.
Women at the Bench
Women scientists, their
accomplishments, and their
career paths are the focus of
the NIEHS Distinguished
Women Scientists Sem- m
inar Series thatwill feature N
five seminars, including
one by Gertrude Elion, 1988 Nobel Laureate
and Scientist Emeritus at Burroughs
Wellcome Company. Suzanne M. Snedeker,
a scientist at NIEHS and chair of the orga-
nizing committee, said, "In addition to pre-
senting a formal research seminar, the speak-
ers also will lead an informal discussion about
the paths their careers have
taken. We hope this dia-
logue presents a rare
opportunity for senior
women scientists to talk to
junior scientists about their
research, and how they
successfully broke through
the 'glass ceiling' that has
affected the advancement
ofwomen scientists."
Sponsored by the NIEHS
Division of Intramural
Research Women Scien-
tists and the NIEHS
Office of the Scientific
Director, the series will
continue from March
through September and is
open to the public. The research seminars
will be held at 10 a.m. in building 101,
conference room B, at NIEHS's South
Campus in Research Triangle Park, North
Carolina. The schedule follows:
* March 2: Patricia K. Donahoe, chief,
Pediatric Surgical Services, Massachusetts
General Hospital. Donahoe was the
NIEHS Hans L. Falk Memorial Lecturer
in 1992 and will speak on "TGF-beta
Receptor Downstream Interactors in
Growth and Differentiation."
* March 31: Alice Huang, dean for science,
New York University, will speak on
"Neuronal Pathways Utilized by Vesicular
Stomatitis Virus after Intranasal Inocu-
lation: Determination of Site(s) for
Interference."
* May 8: Elaine Faustman, professor and
associate chair, Department of Environ-
mental Health, University ofWashington
at Seattle, will speak on "In Vitro
Developmental Toxicity Assessments:
Application forMechanisticEvaluations."
* June 28: Thea Tlsty, associate professor,
University of North Carolina at Chapel
Hill, will speak on "Disruption of
Genomic Integrity in Tumor Pro-
gression."
September 7: Gertrude Elion, 1988 Nobel
\ Laureate and Scientist Emeritus,
Burroughs Wellcome Company, "Chal-
lenges ofPharmaceutical Research."
Forfurther information about the semi-




In January, 60 representatives from 14 coun-
tries, including international and intergov-
ernmental organizations and industrial asso-
ciations, met at the NIEHS to give advice on
prioritizing chemicals for international risk
assessment and related issues. The meeting
was co-sponsored by the International
Programme on Chemical Safety (IPCS) and
the Organisation for Economic Co-opera-
tion and Development (OECD) and sup-
ported by the NIEHS, the EPA, and the
governments ofJapan and Canada.
Since 1973, 284 chemicals have been
recommended to the IPCS to be internation-
ally evaluated for health and environmental
effects, and over 80% ofthese chemicals have
been evaluated in some manner. Criteria
adopted previously for selecting chemicals
for evaluation include:
* Adverse effects: data support the condusion
that thesubstance presents apotential hazard
forhuman healthand/ortheenvironment;
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